Share Email Print

Proceedings Paper

Raman microbeam spectrometer noninvasively measures biomoelcules to monitor the tryptophan metabolic pathway
Author(s): Gregory Michel; Alan W. Bigelow; Jamie Harden; James G. Krueger; Daniel S. Gareau
Format Member Price Non-Member Price
PDF $17.00 $21.00

Paper Abstract

Toward improving early detection of melanoma by accurate diagnosis and avoidance of unnecessary surgical excisions of common moles, we are developing noninvasive quantitative spectral fingerprinting of protein expression using Raman spectroscopy within confocally gated volumes of tissue. Our first target is the L-tryptophan catabolism pathway, which is unregulated in the tumor micro-environment and inhibits the immune response that usually is tumor suppressive. The tryptophan pathway is therefore worthy of diagnostic measurement and finding the ratio of L-tryptophan to its metabolites may aid a melanoma diagnosis. We report the intensity of the Raman signal from L-tryptophan and quinolinic acid, which are found during different stages of the tryptophan metabolic pathway.

Paper Details

Date Published: 4 March 2014
PDF: 6 pages
Proc. SPIE 8947, Imaging, Manipulation, and Analysis of Biomolecules, Cells, and Tissues XII, 894703 (4 March 2014); doi: 10.1117/12.2040322
Show Author Affiliations
Gregory Michel, The Rockefeller Univ. (United States)
Carnegie Mellon Univ. (United States)
Alan W. Bigelow, Columbia Univ. (United States)
Jamie Harden, The Rockefeller Univ. (United States)
James G. Krueger, The Rockefeller Univ. (United States)
Daniel S. Gareau, The Rockefeller Univ. (United States)

Published in SPIE Proceedings Vol. 8947:
Imaging, Manipulation, and Analysis of Biomolecules, Cells, and Tissues XII
Daniel L. Farkas; Dan V. Nicolau; Robert C. Leif, Editor(s)

© SPIE. Terms of Use
Back to Top
Sign in to read the full article
Create a free SPIE account to get access to
premium articles and original research
Forgot your username?